Astrazeneca Pharma India Share Price
Small Cap | Pharmaceuticals and health care | NSE: ASTRAZEN | BSE: 506820
₹7,904.00 -164.55 (-2.04 %)
Last Updated: 04 Apr 2025 03:52 PM
Overview
Open (₹) 8,012.40
High (₹) 8,199.85
Low (₹) 7,857.05
Prev. Close (₹) 8,068.55
Volume 28,883
VWAP (₹) 6,737.67
ROCE (%) 28.34
Industry P/E 44.73
TTM P/E 203.76
P/B Ratio 27.76
Market Cap (₹) Cr.19,760.00
Dividend Yield (%)0.30
EPS (₹) 64.60
ROE22.68%
Sales Growth (%) 29.17
Profit Growth (%)62.66
Day Range
8,199.858,199.85
52 Week Range
5,000.009,049.95
Historical Returns
Returns (6M)
0.75 %
Returns (1Y)
53.57 %
Returns (3Y)
184.04 %
Returns (5Y)
193.43 %
Returns (6M)
0.75 %
Returns (1Y)
53.57 %
Returns (3Y)
184.04 %
Returns (5Y)
193.43 %
SWOT Analysis
- Increasing Revenue every Quarter for the past 4 Quarters
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
RSI 21.48
MFI 34.82
ATR 268.37
Commodity Channel Index -110.90
ROC125 0.56
ROC21 -7.77
Williams %R -97.19
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 6,875.10 | 7,051.55 | 7,154.10 | 6,772.55 | 6,596.10 | 6,493.55 | 6,317.10 |
Week Ago | 6,992.55 | 7,114.80 | 7,207.00 | 6,900.35 | 6,778.10 | 6,685.90 | 6,563.65 |
Month Ago | 7,191.04 | 7,332.07 | 7,517.59 | 7,005.52 | 6,864.49 | 6,678.97 | 6,537.94 |
EMA & SMA
7904.00
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 6859.85
9 Day 6930.18
10 Day 6961.64
12 Day 7106.30
14 Day 7146.54
20 Day 7233.09
26 Day 7172.41
50 Day 7012.14
100 Day 7068.00
200 Day 6824.35
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 07 Oct, 2024 | ₹7,887.16 | 1,25,166 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 07 Oct, 2024 | ₹7,884.41 | 1,25,166 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 30 Sept, 2024 | ₹7,804.96 | 1,27,119 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 30 Sept, 2024 | ₹7,802.00 | 1,27,119 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 24 Sept, 2024 | ₹7,506.36 | 1,31,308 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 24 Sept, 2024 | ₹7,499.17 | 1,31,308 | NSE |
Insider Trading
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
27 May, 2024 | Rs.24.0000 per share(1200%)Dividend | 05 Jul, 2024 | 05 Jul, 2024 |
30 May, 2023 | Rs.16.0000 per share(800%)Dividend | 14 Jul, 2023 | 14 Jul, 2023 |
26 May, 2022 | Rs.8.0000 per share(400%)Final Dividend | 07 Jul, 2022 | 08 Jul, 2022 |
Announcements
Date | Source | Detail |
---|---|---|
04 Apr, 2025 | BSE India | Please find the enclosed intimation of the Company in relation to the captioned subject for your reference. |
04 Apr, 2025 | BSE India | Please find the enclosed intimation of the Company as per the captioned subject for your reference. |
28 Mar, 2025 | NSE India | AstraZeneca Pharma India Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot |
28 Mar, 2025 | BSE India | Please find the enclosed intimation of the Company in relation to the captioned subject for your reference. |
28 Mar, 2025 | BSE India | Please find the enclosed intimation of the Company as per the captioned subject for your reference. |
28 Mar, 2025 | NSE India | AstraZeneca Pharma India Limited has informed the Exchange about General Updates |
22 Mar, 2025 | NSE India | AstraZeneca Pharma India Limited has informed the Exchange regarding ''Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ''. |
19 Mar, 2025 | NSE India | AstraZeneca Pharma India Limited has informed the Exchange regarding ''Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ''. |
14 Mar, 2025 | NSE India | ASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange about Closure of Trading Window |
14 Mar, 2025 | NSE India | AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 21 Jan, 2025 | 11 Feb, 2025 |
Quarterly Results | -- | 28 Oct, 2024 | 13 Nov, 2024 |
Quarterly Results | -- | 25 Jul, 2024 | 08 Aug, 2024 |
Audited Results & Dividend | -- | 16 May, 2024 | 27 May, 2024 |
Quarterly Results | -- | 30 Jan, 2024 | 08 Feb, 2024 |
Quarterly Results | -- | 31 Oct, 2023 | 09 Nov, 2023 |
Quarterly Results | -- | 07 Aug, 2023 | 14 Aug, 2023 |
Audited Results & Dividend | -- | 24 May, 2023 | 30 May, 2023 |
Quarterly Results | -- | 31 Jan, 2023 | 10 Feb, 2023 |
Quarterly Results | -- | 31 Oct, 2022 | 11 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 75% | 75% | 75% | 75% | 75% |
Foreign Institutions + | 2.92% | 2.66% | 2.61% | 2.38% | 2.36% |
Domestic Institutions + | 5.21% | 2.77% | 1.43% | 1.14% | 1.46% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 16.87% | 19.57% | 20.96% | 21.48% | 21.18% |
Others | 0% | 0% | 0% | 0% | 0% |
About Astrazeneca Pharma India
AstraZeneca Pharma India is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1295.53 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2024.
Parent Organisation
AstraZeneca Group
Founded
1979
Managing Director
-- --
NSE Symbol
ASTRAZEN
Astrazeneca Pharma India Management
Name | Designation |
---|---|
Mr. Narayan K Seshadri | Chairperson & Independent Director |
Mr. Sanjeev Kumar Panchal | Executive Director |
Ms. Bhavana Agrawal | Executive Director |
Ms. Sylvia Lorena Varela Ramon | Non Executive Director |
Ms. Hooi Bien Chuah | Non Executive Director |
Ms. Shilpa Divekar Nirula | Independent Director |
Ms. Revathy Ashok | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Astrazeneca Pharma India
What is the share price of Astrazeneca Pharma India?
The share price of Astrazeneca Pharma India on 04 Apr, 2025 is ₹ 7,904.00.
What is 52W high and 52W low share price of Astrazeneca Pharma India?
The highest and lowest 52W share prices of Astrazeneca Pharma India are ₹ 9049.950 and ₹ 5000.000
What is the market cap of Astrazeneca Pharma India?
The market capitalization of Astrazeneca Pharma India as of 04 Apr, 2025 is ₹ 19,760.00 Crores
What is the P/E ratio of Astrazeneca Pharma India?
The current P/E ratio of Astrazeneca Pharma India as of 04 Apr, 2025 is 44.73
What is the PB ratio of Astrazeneca Pharma India?
The PB ratio of Astrazeneca Pharma India as of 04 Apr, 2025 is 27.76
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)